Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Cellectis S.A amends follow-on

    Cellectis S.A. (Euronext:ALCLS), Paris, France Business: Gene/Cell therapy, Genomics Date announced: 2015-02-20 Type: Follow-on To be raised: Up to $115 million Shares: TBD Price prior: EUR12.53 Underwriters: BofA …

    Published on 3/2/2015
  • Opexa Therapeutics Inc amends rights offering

    Opexa Therapeutics Inc. (NASDAQ:OPXA), The Woodlands, Texas Business: Autoimmune, Gene/Cell therapy Date announced: 2015-02-25 Type: Rights offering To be raised: Up to $20.1 million Shares: 28.8 million Price: $0.70 (…

    Published on 3/2/2015
  • Summit Therapeutics pl amends follow-on

    Summit Therapeutics plc (LSE:SUMM), Abingdon, U.K. Business: Musculoskeletal, Infectious Date announced: 2015-02-20 Type: Follow-on To be raised: Up to $46 million Shares: 3.5 million Price prior: 127.5p Underwriters: …

    Published on 3/2/2015
  • Agile Therapeutics Inc completes debt financing

    Agile Therapeutics Inc. (NASDAQ:AGRX), Princeton, N.J. Business: Genitourinary, Endocrine/Metabolic Date completed: 2015-02-24 Type: Debt financing Raised: $16.5 million Investor: Hercules Technology Growth Capital Note…

    Published on 3/2/2015
  • AMAG Pharmaceuticals Inc completes follow-on

    AMAG Pharmaceuticals Inc. (NASDAQ:AMAG), Lexington, Mass. Business: Hematology Date completed: 2015-02-25 Type: Follow-on Raised: $175 million Shares: 4 million Price: $44 Shares after offering: 29.6 million …

    Published on 3/2/2015
  • Cardio3 BioSciences S.A completes private placement

    Cardio3 BioSciences S.A. (Euronext:CARD), Mont-Saint-Guibert, Belgium Business: Cardiovascular Date completed: 2015-02-27 Type: Private placement Raised: EUR31.8 million ($36 million) Shares: 713,380 Price: EUR44.50 …

    Published on 3/2/2015
  • Celldex Therapeutics Inc completes follow-on

    Celldex Therapeutics Inc. (NASDAQ:CLDX), Needham, Mass. Business: Cancer, Infectious, Renal Date completed: 2015-02-25 Type: Follow-on Raised: $174 million Shares: 7.3 million Price: $24 Shares after offering: 96.8 …

    Published on 3/2/2015
  • Chiasma completes venture financing

    Chiasma Inc., Jerusalem, Israel Business: Endocrine/Metabolic, Infectious, Drug delivery Date completed: 2015-02-27 Type: Venture financing Raised: $70 million Investors: Rock Springs Capital; Sofinnova Ventures; MPM …

    Published on 3/2/2015
  • CollabRx Inc completes follow-on

    CollabRx Inc. (NASDAQ:CLRX), San Francisco, Calif. Business: Bioinformatics Date completed: 2015-02-25 Type: Follow-on Raised: $3 million Shares: 2.4 million Price: $1.27 Shares after offering: 9.1 million Underwriter: …

    Published on 3/2/2015
  • Curis Inc completes follow-on

    Curis Inc. (NASDAQ:CRIS), Lexington, Mass. Business: Cancer Date completed: 2015-02-25 Type: Follow-on Raised: $60 million Shares: 21.8 million Price: $2.75 Shares after offering: 107.8 million Underwriters: Cowen; RBC …

    Published on 3/2/2015
  • Dance Biopharm completes venture financing

    Dance Biopharm Inc., Brisbane, Calif. Business: Endocrine/Metabolic Date completed: 2015-02-18 Type: Venture financing Raised: $9.5 million Placement agent: SternAegis Ventures Investors: Individual investors; …

    Published on 3/2/2015
  • EyeGate Pharmaceuticals Inc completes IPO

    EyeGate Pharmaceuticals Inc. (OTCQB:EYEG), Waltham, Mass. Business: Ophthalmic Date completed: 2015-02-19 Type: IPO Raised: $4.1 million Shares: 683,250 Price: $6 Shares after offering: 6.3 million Underwriters: Aegis …

    Published on 3/2/2015
  • Great Basin Corp completes private placement of units

    Great Basin Corp. (NASDAQ:GBSN), Salt Lake City, Utah Business: Diagnostic Date completed: 2015-02-26 Type: Private placement of units Raised: $24 million Units: 2.7 million Price: $8.80 (unit) Shares outstanding prior:…

    Published on 3/2/2015
  • InMed Pharmaceuticals Inc completes private placement of units

    InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF), Vancouver, B.C. Business: Ophthalmic, Dermatology Date completed: 2015-02-25 Type: Private placement of units Raised: C$1.1 million ($834,645) Units: 10.5 million Price…

    Published on 3/2/2015
  • Intellimedix completes venture financing

    Intellimedix Inc., Atlanta, Ga. Business: Neurology Date completed: 2015-02-23 Type: Venture financing Raised: Not disclosed Investor: Private investor Note: The amount raised is not disclosed.

    Published on 3/2/2015
  • Lion Biotechnologies Inc completes follow-on

    Lion Biotechnologies Inc. (NASDAQ:LBIO), Woodland Hills, Calif. Business: Cancer Date completed: 2015-02-26 Type: Follow-on Raised: $64 million Shares: 8 million Price: $8 Shares after offering: 42.9 million …

    Published on 3/2/2015
  • Lyric Pharmaceuticals completes venture financing

    Lyric Pharmaceuticals Inc., South San Francisco, Calif. Business: Gastrointestinal Date completed: 2015-02-26 Type: Venture financing Raised: $20.4 million Investors: RiverVest Venture Partners; Sante Ventures LLC; …

    Published on 3/2/2015
  • Neos Therapeutics completes venture financing

    Neos Therapeutics Inc., Grand Prairie, Texas Business: Drug delivery, Neurology Date completed: 2015-02-25 Type: Venture financing Raised: $20.6 million Investors: Presidio Partners; Crabtree Partners; CAC LLC; Delaware…

    Published on 3/2/2015
  • Prexton Therapeutics completes venture financing

    Prexton Therapeutics S.A., Plan les Ouates, Switzerland Business: Neurology Date completed: 2015-02-24 Type: Venture financing Raised: EUR8.7 million ($9.9 million) Investors: Sunstone; Ysios Capital Partners; MS …

    Published on 3/2/2015
  • Relypsa Inc completes follow-on

    Relypsa Inc. (NASDAQ:RLYP), Redwood City, Calif. Business: Endocrine/Metabolic Date completed: 2015-02-25 Type: Follow-on Raised: $150.2 million Shares: 3.9 million Price: $38.50 Shares after offering: 40.4 million …

    Published on 3/2/2015
  • Spring Bank completes venture financing

    Spring Bank Pharmaceuticals Inc., Milford, Mass. Business: Infectious, Pulmonary Date completed: 2015-02-26 Type: Venture financing Raised: $22 million

    Published on 3/2/2015
  • Transgenomic Inc completes follow-on

    Transgenomic Inc. (NASDAQ:TBIO), Omaha, Neb. Business: Supply/Service, Diagnostic Date completed: 2015-02-27 Type: Follow-on Raised: $7 million Shares: 3.6 million Price: $1.95 Shares after offering: 11.9 million …

    Published on 3/2/2015
  • Vigilant Biosciences completes venture financing

    Vigilant Biosciences Inc., Miami, Fla. Business: Diagnostic Date completed: 2015-02-24 Type: Venture financing Raised: $5.5 million Investors: White Owl Capital Partners; venVelo; Florida Institute for Commercialization…

    Published on 3/2/2015
  • Xencor Inc completes follow-on

    Xencor Inc. (NASDAQ:XNCR), Monrovia, Calif. Business: Cancer, Autoimmune, Antibodies Date completed: 2015-02-25 Type: Follow-on Raised: $106.9 million Shares: 7.5 million Price: $14.25 Shares after offering: 38.9 …

    Published on 3/2/2015
  • Illumina Inc financial update

    Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Business: Microarrays, Genomics, Supply/Service Date announced: 2015-02-26 Note: Illumina raised $40 million from Viking Global Investors for its Accelerator Boost Capital …

    Published on 3/2/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993